Minimal Residual Disease Status with Venetoclax Monotherapy Is Associated with Progression-Free Survival in Chronic Lymphocytic Leukemia
Year: 2018
Type: conference-abstract
Source: Blood
Authors: William G. Wierda, Andrew W. Roberts, Paolo Ghia, Jennifer R. Brown, Stephan Stilgenbauer, Florence Cymbalista, Nicole Lamanna, John F. Seymour, Sebastian Böttcher, Madlaina Breuleux, Brenda Chyla, Lang Zhou, Jacqueline Nielsen, Su Young Kim, Jalaja Potluri, Johnathan C. Maher, Peter Hillmen
Institutions: The University of Texas MD Anderson Cancer Center, The Royal Melbourne Hospital, Walter and Eliza Hall Institute of Medical Research, Peter MacCallum Cancer Centre, Vita-Salute San Raffaele University, IRCCS San Raffaele Roma, Dana-Farber Cancer Institute, Universität Ulm, Hôpital Avicenne, Laboratoire d'hématologie, Columbia University Irving Medical Center, Christian-Albrechts-Universität zu Kiel, University Hospital Schleswig-Holstein, University of Rostock, F. Hoffmann-La Roche AG, AbbVie (United States), St James's University Hospital
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2908723594